Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 12/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | TNKS | O95271 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | TTR | P02766 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12610079 | 0.81 | AHR (0.49) | AHRSMN1; SMN2KDM4EMEN1ALDH1A1 | |
| SCHEMBL20739897 | 0.81 | AHR (0.62) | AHRSMN1; SMN2TTR | |
| SCHEMBL20726239 | 0.79 | AHR (0.46) | AHRSMN1; SMN2TNKSKDM4EMEN1 | |
| SCHEMBL29819424 | 0.79 | AHR (0.46) | AHRSMN1; SMN2TNKSKDM4EMEN1 | |
| SCHEMBL12610390 | 0.79 | AHR (0.46) | AHRSMN1; SMN2TNKSKDM4EMEN1 | |
| SCHEMBL30018586 | 0.79 | AHR (0.54) | AHRSMN1; SMN2TNKSKDM4EMEN1 | |
| SCHEMBL18594297 | 0.79 | AHR (0.54) | AHRSMN1; SMN2TNKSKDM4EMEN1 | |
| SCHEMBL22815436 | 0.79 | AHR (0.60) | AHRSMN1; SMN2MEN1ALDH1A1MAPT | |
| SCHEMBL17166654 | 0.79 | AHR (0.54) | AHRSMN1; SMN2TNKSKDM4EMEN1 | |
| SCHEMBL25567555 | 0.78 | AHR (0.45) | AHRALDH1A1MAPTHPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12102003-B2 | Organic electroluminescent devices and electronic apparatus | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2024-09-24 | — | — | US | disclosed |
| US-20230397493-A1 | ORGANIC ELECTROLUMINESCENT DEVICES AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-12-07 | — | — | US | disclosed |
| US-11778901-B2 | Organic electroluminescent material and organic electroluminescent device comprising same | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-10-03 | — | — | US | disclosed |
| US-11778901-B2 | Organic electroluminescent material and organic electroluminescent device comprising same | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-10-03 | — | — | US | disclosed |
| US-11723271-B2 | Organic compound, and electronic component and electronic device therefor | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-08 | — | — | US | disclosed |
| US-11723271-B2 | Organic compound, and electronic component and electronic device therefor | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-08 | — | — | US | disclosed |
| US-20230200234-A1 | ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE THEREFOR | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
| US-20230200234-A1 | ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE THEREFOR | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
| WO-2023087557-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC DEVICE | 陕西莱特光电材料股份有限公司 | 2023-05-25 | — | — | WO | disclosed |
| WO-2023087557-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC DEVICE | 陕西莱特光电材料股份有限公司 | 2023-05-25 | — | — | WO | disclosed |
| WO-2022206396-A1 | HOST MATERIAL COMPOSITION, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS | 陕西莱特光电材料股份有限公司 | 2022-10-06 | — | — | WO | disclosed |
| WO-2022156445-A1 | ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE THEREFOR | 陕西莱特光电材料股份有限公司 | 2022-07-28 | — | — | WO | disclosed |
| US-20220149278-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-05-12 | — | — | US | disclosed |
| WO-2020253445-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 陕西莱特光电材料股份有限公司 | 2020-12-24 | — | — | WO | disclosed |
| WO-2020253445-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 陕西莱特光电材料股份有限公司 | 2020-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230200234-A1 | ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE THEREFOR | OR51E2, CYP4F11, OR10J3 | AHR 42/4885SMN1; SMN2 3420/4885TNKS 4748/4885 |
| US-11723271-B2 | Organic compound, and electronic component and electronic device therefor | OR51E2, CYP4F11, OR10J3 | AHR 42/4885SMN1; SMN2 3420/4885TNKS 4748/4885 |
| US-11778901-B2 | Organic electroluminescent material and organic electroluminescent device comprising same | MAOA, AOC1, AOC2 | AHR 1588/4885SMN1; SMN2 2442/4885TNKS 4120/4885 |
| US-20220149278-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | MAOA, AOC1, AOC2 | AHR 1571/4885SMN1; SMN2 2450/4885TNKS 4143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.